Clearmind Medicine Shares Are Trading Higher After the Company Announced It Has Received Institutional Review Board Approval From One of Its Clinical Sites in the U.S. for Part A of Its Phase I/IIa Clinical Trial in the United States for Treating...

Clearmind藥物股份正在交易更高，因爲公司宣佈其在美國的臨床研究部分A的I / IIa臨床試驗獲得了機構審查委員會的批准，用於治療...

Benzinga · 10/10 20:15

Clearmind Medicine Shares Are Trading Higher After the Company Announced It Has Received Institutional Review Board Approval From One of Its Clinical Sites in the U.S. for Part A of Its Phase I/IIa Clinical Trial in the United States for Treating Patients Suffering From Alcohol Use Disorder.

Clearmind Medicine股票交易上漲，公司宣佈已經獲得美國一家臨床試驗點的機構審查委員會批准，用於治療酒精濫用障礙患者的I/IIa期臨床試驗A部分。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。